<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">JCN</journal-id>
<journal-id journal-id-type="hwp">spjcn</journal-id>
<journal-id journal-id-type="nlm-ta">J Child Neurol</journal-id>
<journal-title>Journal of Child Neurology</journal-title>
<issn pub-type="ppub">0883-0738</issn>
<issn pub-type="epub">1708-8283</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0883073811423975</article-id>
<article-id pub-id-type="publisher-id">10.1177_0883073811423975</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Original Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Cerebellar Axon/Myelin Loss, Angiogenic Sprouting, and Neuronal Increase of Vascular Endothelial Growth Factor in a Preterm Infant with Kernicterus</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Brito</surname>
<given-names>Maria A.</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="aff1-0883073811423975">1</xref>
<xref ref-type="corresp" rid="corresp1-0883073811423975"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zurolo</surname>
<given-names>Emanuele</given-names>
</name>
<degrees>MSc</degrees>
<xref ref-type="aff" rid="aff2-0883073811423975">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Pereira</surname>
<given-names>Pedro</given-names>
</name>
<degrees>MSc</degrees>
<xref ref-type="aff" rid="aff3-0883073811423975">3</xref>
<xref ref-type="aff" rid="aff4-0883073811423975">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Barroso</surname>
<given-names>Cândida</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff3-0883073811423975">3</xref>
<xref ref-type="aff" rid="aff4-0883073811423975">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Aronica</surname>
<given-names>Eleonora</given-names>
</name>
<degrees>MD, PhD</degrees>
<xref ref-type="aff" rid="aff2-0883073811423975">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Brites</surname>
<given-names>Dora</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="aff1-0883073811423975">1</xref>
</contrib>
</contrib-group>
<aff id="aff1-0883073811423975">
<label>1</label>Research Institute for Medicines and Pharmaceutical Sciences (iMed.UL) and Department of Biochemistry and Human Biology, Faculty of Pharmacy, University of Lisbon, Lisbon, Portugal</aff>
<aff id="aff2-0883073811423975">
<label>2</label>Department of (Neuro)Pathology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands</aff>
<aff id="aff3-0883073811423975">
<label>3</label>Laboratory of Neuropathology, Centro Hospitalar Lisboa Norte, Hospital de Santa Maria, Lisbon, Portugal</aff>
<aff id="aff4-0883073811423975">
<label>4</label>Neuromuscular Unit, Institute of Molecular Medicine, Faculty of Medicine, University of Lisbon, Lisbon, Portugal</aff>
<author-notes>
<corresp id="corresp1-0883073811423975">Maria A. Brito, PhD, Faculdade de Farmácia da Universidade de Lisboa, Av. Prof. Gama Pinto 1649-003 Lisbon, Portugal Email: <email>abrito@ff.ul.pt</email>
</corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>5</month>
<year>2012</year>
</pub-date>
<volume>27</volume>
<issue>5</issue>
<fpage>615</fpage>
<lpage>624</lpage>
<history>
<date date-type="received">
<day>16</day>
<month>6</month>
<year>2011</year>
</date>
<date date-type="rev-recd">
<day>22</day>
<month>8</month>
<year>2011</year>
</date>
<date date-type="accepted">
<day>27</day>
<month>8</month>
<year>2011</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author(s) 2012</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="sage">SAGE Publications</copyright-holder>
</permissions>
<abstract>
<p>We performed histologic and immunohistochemical analysis of cerebellar sections from a preterm infant (32 weeks 5 days) dead on the 4th day of life with the diagnosis of kernicterus and compared the results with 1 age-matched nonicteric patient. Poorer Luxol fast blue–periodic acid Schiff and Bodian-Luxol fast blue stainings as well as neurofilament expression were observed in the kernicterus case, indicating loss of axon neurites and myelin fibers. Elevated claudin-5 and cluster of differentiation 34 expression associated with increased blood vessel density suggests bilirubin-induced angiogenic sprouting. Upregulation of vascular endothelial growth factor and its receptor 2 was observed in nucleus dentatus and Purkinje neurons. Although upregulation of multidrug resistance–associated protein 1 was increased in cerebellar neurons, it was not able to prevent bilirubin-induced neurotoxicity. These data add new insights into the pathophysiology of kernicterus, revealing vascular endothelial growth factor and its receptor 2, as well as angiogenic sprouting, as new players in neurologic damage by unconjugated bilirubin.</p>
</abstract>
<kwd-group>
<kwd>angiogenesis</kwd>
<kwd>kernicterus</kwd>
<kwd>multidrug resistance–associated protein 1</kwd>
<kwd>neuronal impairment</kwd>
<kwd>vascular endothelial growth factor</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<p>Moderate jaundice is observed in approximately 60% of healthy term neonates, usually representing a benign physiologic process without sequelae.<sup>
<xref ref-type="bibr" rid="bibr1-0883073811423975">1</xref>
</sup> In contrast, severe hyperbilirubinemia occurs in 8% to 9% of infants during the first week<sup>
<xref ref-type="bibr" rid="bibr2-0883073811423975">2</xref>
</sup> and can cause a spectrum of neurological deficits that may culminate in kernicterus.<sup>
<xref ref-type="bibr" rid="bibr3-0883073811423975">3</xref>
</sup> The early hospital discharge of term infants and the increased survival of prematurely born infants, as well as the increase in breastfeeding, led to the resurgence of kernicterus cases. Also related to that is the lack of adequate concern for the risks of excessive jaundice in healthy term and near-term newborns, once kernicterus had nearly disappeared in full-term infants,<sup>
<xref ref-type="bibr" rid="bibr4-0883073811423975">4</xref>
<xref ref-type="bibr" rid="bibr5-0883073811423975"/>
<xref ref-type="bibr" rid="bibr6-0883073811423975"/>–<xref ref-type="bibr" rid="bibr7-0883073811423975">7</xref>
</sup> what brought this severe pathologic condition to light again.</p>
<p>The multidrug resistance–associated protein 1 appears to play a role in the cellular defense mechanisms against unconjugated bilirubin neurotoxicity, as inhibition of such efflux transporter enhanced bilirubin toxicity to neural cells, whereas decreased expression in poorly differentiated cells was associated with a greater vulnerability to bilirubin damage.<sup>
<xref ref-type="bibr" rid="bibr8-0883073811423975">8</xref>
</sup> On the other hand, bilirubin binding to cells and toxicity were enhanced in less-differentiated cells<sup>
<xref ref-type="bibr" rid="bibr1-0883073811423975">1</xref>,<xref ref-type="bibr" rid="bibr9-0883073811423975">9</xref>
</sup> and in acidic medium,<sup>
<xref ref-type="bibr" rid="bibr10-0883073811423975">10</xref>
</sup> as well as in the presence of lipopolysaccharide<sup>
<xref ref-type="bibr" rid="bibr11-0883073811423975">11</xref>
</sup> or proinflammatory cytokines,<sup>
<xref ref-type="bibr" rid="bibr12-0883073811423975">12</xref>
</sup> in accordance with the increased risk of neurotoxicity in premature jaundiced infants, mainly when associated with acidosis and infection.<sup>
<xref ref-type="bibr" rid="bibr1-0883073811423975">1</xref>,<xref ref-type="bibr" rid="bibr13-0883073811423975">13</xref>,<xref ref-type="bibr" rid="bibr14-0883073811423975">14</xref>
</sup> Besides impairment of the neurite network and the production of oxidative stress, unconjugated bilirubin also revealed immunostimulant effects.<sup>
<xref ref-type="bibr" rid="bibr9-0883073811423975">9</xref>,<xref ref-type="bibr" rid="bibr11-0883073811423975">11</xref>,<xref ref-type="bibr" rid="bibr15-0883073811423975">15</xref>
<xref ref-type="bibr" rid="bibr16-0883073811423975"/>–<xref ref-type="bibr" rid="bibr17-0883073811423975">17</xref>
</sup> One of the cytokines produced by human brain microvascular endothelial cells when exposed to bilirubin was the vascular endothelial growth factor,<sup>
<xref ref-type="bibr" rid="bibr18-0883073811423975">18</xref>
</sup> which is known to have a role in angiogenesis and in vascular permeability. The production of vascular endothelial growth factor was shown to be stimulated by heme oxygenase 1,<sup>
<xref ref-type="bibr" rid="bibr19-0883073811423975">19</xref>
</sup> the enzyme involved in bilirubin production. Furthermore, hyperpermeability is a downstream event resulting from the binding of vascular endothelial growth factor to its receptor 2 and has been linked to oxidative stress.<sup>
<xref ref-type="bibr" rid="bibr20-0883073811423975">20</xref>
</sup>
</p>
<p>At autopsy, kernicteric infants revealed visible bilirubin staining within the basal ganglia, hippocampus, lateral ventricular walls, subthalamic nuclei, mid brain, pons, cerebellum, and inferior cerebellar peduncles, together with brain edema,<sup>
<xref ref-type="bibr" rid="bibr21-0883073811423975">21</xref>
</sup> reflecting a preferential deposition of bilirubin in specific areas of the brain in these infants and suggesting an enhanced permeability of vascular walls. Demyelination has also been shown in the affected areas, together with prominent gliosis.<sup>
<xref ref-type="bibr" rid="bibr3-0883073811423975">3</xref>
</sup> Interestingly, early white matter changes were previously observed by magnetic resonance imaging (MRI) late scans both in term and preterm infants.<sup>
<xref ref-type="bibr" rid="bibr22-0883073811423975">22</xref>
</sup> Neurons especially susceptible to bilirubin poisoning are the Purkinje cells in the cerebellum.<sup>
<xref ref-type="bibr" rid="bibr23-0883073811423975">23</xref>
</sup> Moreover, cerebellar hypoplasia and profound loss of Purkinje and granule neurons have been reported in the homozygous Gunn rat, a genetic model of hyperbilirubinemia-induced neurotoxicity.<sup>
<xref ref-type="bibr" rid="bibr24-0883073811423975">24</xref>
</sup> Therefore, we decided to study the cerebellum in 1 autopsy case of kernicterus, focusing on the analysis of neurons and myelin fibers, brain microvasculature, and multidrug resistance–associated protein 1 expression. By revealing vascular endothelial growth factor/vascular endothelial growth factor receptor 2 and neovascularization as new players in neurodegeneration, this case report provides new insights into the pathophysiology of kernicterus.</p>
<sec id="section1-0883073811423975">
<title>Case Report</title>
<sec id="section2-0883073811423975">
<title>Clinical Summary</title>
<p>A girl was born preterm at 32 weeks 5 days with a weight of 1600 g, and Apgar score of 6 at 1 minute and 7 at 5 minutes, requiring artificial ventilation. A cranial ultrasound scan did not reveal cerebral pathology. Evidence of focal pulmonary infiltration was noted on the radiograph. Total bilirubin levels on the 1st, 2nd and 4th postnatal days were 13.1, 28.8, and 21.4 mg/dL, respectively, and the serum albumin was 3.3 g/dL on day 2 and 3.2 g/dL on day 4. Intensive phototherapy (blue light) was initiated on the 2nd day and antibiotic therapy (penicillin, gentamicin, and flucloxacillin) on the 1st day of life because of suspicion of sepsis. The clinical course was dominated by a rapid deterioration of the clinical condition with high-pitch cry; poor suckling; hypotonia; hypotension; bradycardia; metabolic acidosis; development of generalized seizures, which did not respond to the pharmacological treatment initiated on the 3rd postnatal day (phenobarbital, midazolam, clonazepam, and lidocaine); and progressive cardiorespiratory problems. The child died on the 4th day of life and autopsy was performed.</p>
<p>Data were compared with autopsy material from a male preterm born at 30 weeks with a birth weight of 1450 g who died from cardiorespiratory failure on the 14th day of life, with sepsis and without history of hyperbilirubinemia. Sections from a female born at 40 weeks with a weight 3225 g who died from cardiorespiratory failure on the 1st day of life, with pneumonia, without history of hyperbilirubinemia were used as a positive control for Bodian-Luxol fast blue staining.</p>
<p>Brain tissue was formalin-fixed and, following macroscopic assessment, was paraffin embedded, sectioned at 6 μm, and mounted on organosilane-coated slides (Sigma, St Louis, Missouri) for microscopic examination.</p>
</sec>
</sec>
<sec id="section3-0883073811423975">
<title>Pathologic Findings</title>
<p>Fixed coronal sections of the cerebral hemispheres revealed marked yellow staining of cerebellum, as well as of hippocampus, thalamus, globus pallidus, and subthalamic nuclei; vestibular nucleus, cochlear nucleus, and medial lemniscus of the medulla oblongata also showed yellow discoloration. No developmental abnormalities were detected. The brain was of normal size for the patient’s age, weighing after fixation 260 g. Signs of meconium aspiration were observed but no other evidence of infection or hemolysis was found in any of the other organ systems. The diagnosis of kernicterus was established. Light ischemic alterations were also observed with focal neuronal loss, but no eosinophilia and only focally karyorrhexis, with no Bergmann gliosis. Sections from the cerebellum were currently reevaluated regarding additional microscopic features.</p>
<p>To visualize myelin fibers, histologic staining with conventional Luxol fast blue–periodic acid Schiff was performed in the kernicterus case, in parallel with the nonicteric baby. The cerebellum of the kernicterus case presented a poorer staining intensity than that of the nonicteric one (<xref ref-type="fig" rid="fig1-0883073811423975">Figure 1A</xref> and <xref ref-type="fig" rid="fig1-0883073811423975">B</xref>). This observation indicates a decreased density of myelinated fibers in the kernicterus case, which is consistent with the clinical feature of demyelination.<sup>
<xref ref-type="bibr" rid="bibr3-0883073811423975">3</xref>
</sup> To further assess axonal integrity, the Bodian-Luxol fast blue technique was used, which revealed that axons were severely affected by hyperbilirubinemia as compared with both the nonicteric case (<xref ref-type="fig" rid="fig1-0883073811423975">Figure 1C</xref> and <xref ref-type="fig" rid="fig1-0883073811423975">D</xref>) and the positive control performed in parallel to guarantee the observations (inset in <xref ref-type="fig" rid="fig1-0883073811423975">Figure 1D</xref>). Impairment of neuritic network was further confirmed by analysis of the immunoreactivity of neurofilaments using an anti-neurofilaments antibody (from Zymed). A poorer reactivity for the neuronal cytoskeleton protein was observed in white matter tracts, reflecting a loss of axons, but also in Purkinje neurons, compatible with a loss of the dendritic arborization (<xref ref-type="fig" rid="fig1-0883073811423975">Figure 1E</xref>-<xref ref-type="fig" rid="fig1-0883073811423975">H</xref>).</p>
<fig id="fig1-0883073811423975" position="float">
<label>Figure 1.</label>
<caption>
<p>Histologic analysis of the cerebellum reveals a loss of myelin fibers, as well as of axons and dendritic arborization in the kernicterus case (<italic>left panel</italic>) when compared with the nonicteric case (<italic>right panel</italic>), as indicated by the poor Luxol fast blue–periodic acid Schiff (<bold>A</bold> and <bold>B</bold>) and Bodian-Luxol fast blue (<bold>C</bold> and <bold>D</bold>) staining, and neurofilaments immunoreactivity (<bold>E</bold>-<bold>H</bold>). Inset in <bold>D</bold> shows positive staining for Bodian-Luxol fast blue in a sample from an adult individual with no axonal loss. Scale bars: <bold>A</bold>-<bold>D</bold>, 200 μm; <bold>E</bold>-<bold>H</bold>, 40 μm.</p>
</caption>
<graphic alternate-form-of="fig1-0883073811423975" xlink:href="10.1177_0883073811423975-fig1.tif"/>
</fig>
<p>The expression of claudin-5, the widely used marker of tight junctions in brain microvasculature, was assessed by immunohistochemical analysis<sup>
<xref ref-type="bibr" rid="bibr25-0883073811423975">25</xref>,<xref ref-type="bibr" rid="bibr26-0883073811423975">26</xref>
</sup> using an anti-claudin-5 primary antibody (from Abcam). As shown in <xref ref-type="fig" rid="fig2-0883073811423975">Figure 2A</xref> and B, a higher number of vessels per brain area was observed in the kernicteric case, as indicated by the increase in the stained structures per field. This unsuspected observation was confirmed by analysis of the adherens junction protein β-catenin (data not shown). To more firmly establish this observation, blood vessels were quantified as vessel area per optical field in claudin-5-stained sections of both patients. The results obtained confirmed the qualitative analysis, as depicted in <xref ref-type="fig" rid="fig2-0883073811423975">Figure 2C</xref> and <xref ref-type="fig" rid="fig2-0883073811423975">D</xref>. In fact, data demonstrated an increase in the area occupied by blood vessels per square millimeter of brain tissue, corresponding to approximately sixfold elevation of the vascularization in the kernicteric brain relatively to the nonicteric sample. This observation was confirmed by immunohistochemical analysis of the endothelial cell marker cluster of differentiation 34 (using an antibody from Dako) (<xref ref-type="fig" rid="fig3-0883073811423975">Figure 3A</xref> and <xref ref-type="fig" rid="fig3-0883073811423975">B</xref>), which further revealed that a significant part of the vessels in the kernicterus case was still primitive, with a poorly developed lumina (<xref ref-type="fig" rid="fig3-0883073811423975">Figure 3C</xref> and <xref ref-type="fig" rid="fig3-0883073811423975">D</xref>).</p>
<fig id="fig2-0883073811423975" position="float">
<label>Figure 2.</label>
<caption>
<p>Analysis of the cerebellum shows an increased expression of claudin-5 and enhanced vascularization in the kernicterus patient compared with the nonicteric patient. Immunohistochemical analysis of the kernicterus case (<bold>A</bold>) and the nonicteric patient (<bold>B</bold>). Scale bars: 200 μm. Results of quantitative analysis were expressed as blood vessel area per square millimeter of brain tissue (<bold>C</bold>) and as fold increase from control (<bold>D</bold>).</p>
</caption>
<graphic alternate-form-of="fig2-0883073811423975" xlink:href="10.1177_0883073811423975-fig2.tif"/>
</fig>
<fig id="fig3-0883073811423975" position="float">
<label>Figure 3.</label>
<caption>
<p>Immunohistochemical analysis of cluster of differentiation 34 in the cerebellum shows an increased number of vessels and a more poorly developed lumen in the kernicterus patient compared with the nonicteric patient. Immunohistochemical analysis of the kernicterus patient (<bold>A</bold> and <bold>C</bold>) and the nonicteric patient (<bold>B</bold> and <bold>D</bold>). Scale bars: <bold>A</bold> and <bold>B</bold>, 200 μm; <bold>C</bold> and <bold>D</bold>, 40 μm.</p>
</caption>
<graphic alternate-form-of="fig3-0883073811423975" xlink:href="10.1177_0883073811423975-fig3.tif"/>
</fig>
<p>The increased immunoreactivity on labeling with claudin-5 and cluster of differentiation 34 suggested that endothelial proliferation was a feature in the pre-term infant with kernicterus. To test the hypothesis that vascular alterations are an underlying event in the pathophysiology of kernicterus, at least in preterm infants, we next examined the expression of vascular endothelial growth factor. Confirming our hypothesis, vascular endothelial growth factor staining (<xref ref-type="fig" rid="fig4-0883073811423975">Figure 4A-D</xref>) was indeed increased in the cerebellum of the kernicterus patient, particularly in Purkinje neurons that were virtually all labeled (<xref ref-type="fig" rid="fig4-0883073811423975">Figure 4C</xref>), though neurons of the nucleus dentatus exhibited a clear staining as well (<xref ref-type="fig" rid="fig4-0883073811423975">Figure 4A</xref>). Therefore, we decided to also evaluate the expression of the protein receptor, the vascular endothelial growth factor receptor 2. Analysis of paraffin sections of the control patient after labeling with the anti–vascular endothelial growth factor receptor 2 antibody did not reveal blood vessels staining in any case (<xref ref-type="fig" rid="fig4-0883073811423975">Figure 4E-H</xref>). In contrast, a notorious staining was observed in neurons of the kernicterus sections, reflecting an enhancement of the receptor expression in the pathologic condition (<xref ref-type="fig" rid="fig4-0883073811423975">Figure 4E and G</xref>), compared with that of the nonicteric patient, which paralleled the observations concerning vascular endothelial growth factor expression.</p>
<fig id="fig4-0883073811423975" position="float">
<label>Figure 4.</label>
<caption>
<p>Immunohistochemical analysis of cerebellum sections reveals an increased expression of vascular endothelial growth factor and vascular endothelial growth factor receptor 2 in the kernicterus case (<italic>left panels</italic>) compared with the nonicteric patient (<italic>right panels</italic>). <bold>A</bold>-<bold>D</bold>, vascular endothelial growth factor; <bold>E</bold>-<bold>H</bold>, vascular endothelial growth factor receptor 2. The enhanced vascular endothelial growth factor and its receptor 2 expression (<italic>arrows</italic>) were most notorious in neurons from nucleus dentatus (<bold>A</bold> and <bold>E</bold>) and Purkinje layer (<bold>C</bold> and <bold>G</bold>). Scale bars: <bold>A</bold>-<bold>D</bold>, 80 μm; <bold>E</bold>-<bold>H</bold>, 160 μm.</p>
</caption>
<graphic alternate-form-of="fig4-0883073811423975" xlink:href="10.1177_0883073811423975-fig4.tif"/>
</fig>
<p>Once a decreased expression of the ATP-binding cassette transporter multidrug resistance–associated protein 1 in the brain may cause accumulation of bilirubin in the parenchyma,<sup>27</sup> we decided to analyze the transporter expression in the kernicterus and in the nonicteric infants. Analysis of multidrug resistance–associated protein 1 immunocytochemistry revealed an increased staining in the kernicterus sample compared with the nonicteric one. The enhanced expression of this transporter was most notorious in neurons, and was observed both in nucleus dentatus (<xref ref-type="fig" rid="fig5-0883073811423975">Figure 5A</xref> vs. <xref ref-type="fig" rid="fig5-0883073811423975">B</xref>) and in Purkinje cells (<xref ref-type="fig" rid="fig5-0883073811423975">Figure 5C</xref> vs. <xref ref-type="fig" rid="fig5-0883073811423975">D</xref>).</p>
<fig id="fig5-0883073811423975" position="float">
<label>Figure 5.</label>
<caption>
<p>Immunohistochemical analysis of cerebellum sections reveals an increased expression of multidrug resistance–associated protein 1 in the kernicterus case (left panels) compared with the nonicteric patient (<italic>right panels</italic>). <bold>A</bold> and <bold>B</bold>, Nucleus dentatus; <bold>C</bold> and <bold>D</bold>, Purkinje cell layer. The enhanced multidrug resistance–associated protein 1 expression (<italic>arrows</italic>) was most notorious in neurons from nucleus dentatus (<bold>A</bold>) and Purkinje layer (<bold>C</bold>). Scale bars: 160 μm.</p>
</caption>
<graphic alternate-form-of="fig5-0883073811423975" xlink:href="10.1177_0883073811423975-fig5.tif"/>
</fig>
</sec>
<sec id="section4-0883073811423975">
<title>Discussion</title>
<p>The pathogenesis of kernicterus is multifactorial, involving the passage of bilirubin or albumin-bound bilirubin across the blood-brain barrier and delivery of bilirubin to target neurons.<sup>
<xref ref-type="bibr" rid="bibr28-0883073811423975">28</xref>
</sup> Among the factors governing bilirubin entry into the brain is the opening of the blood-brain barrier and the increased brain blood flow,<sup>
<xref ref-type="bibr" rid="bibr28-0883073811423975">28</xref>,<xref ref-type="bibr" rid="bibr29-0883073811423975">29</xref>
</sup> whereas among those that limit central nervous system uptake and retention of bilirubin is the multidrug resistance–associated protein 1.<sup>
<xref ref-type="bibr" rid="bibr27-0883073811423975">27</xref>
</sup>
</p>
<p>An interesting observation of this study was the higher density of cerebellar blood vessels, revealed by the increased number of structures labeled with antibodies against claudin-5 and cluster of differentiation 34 per field and suggesting that bilirubin stimulates angiogenesis within the brain. The poorly developed lumen, characteristic of primitive vessels,<sup>
<xref ref-type="bibr" rid="bibr30-0883073811423975">30</xref>
</sup> observed in the kernicterus case suggests that proliferation, sprouting and migration of endothelial cells was induced by bilirubin. Since newly formed blood vessels are typically leaky and do not present well established tight junctions, these observations indicate that endothelial cells exposed to hyperbilirubinemia express increased levels of claudin-5, though it may not be localized at tight junctions. This feature is not without precedent, as Raimondi et al<sup>
<xref ref-type="bibr" rid="bibr31-0883073811423975">31</xref>
</sup> reported a redistribution of tight junctional occludin induced by bilirubin in an in vitro model of the intestinal epithelial barrier. Such delocalization from the membrane to the cytosol has been observed by exposure to other insults, such as phenol,<sup>
<xref ref-type="bibr" rid="bibr32-0883073811423975">32</xref>
</sup> and was attributed to membrane impairment, also occurring by exposure to bilirubin.<sup>
<xref ref-type="bibr" rid="bibr33-0883073811423975">33</xref>,<xref ref-type="bibr" rid="bibr34-0883073811423975">34</xref>
</sup> On the other hand, a cellular redistribution of several junctional proteins and an increased expression of the adherens junction protein β-catenin were recently observed in human brain microvascular endothelial cells exposed to bilirubin.<sup>
<xref ref-type="bibr" rid="bibr18-0883073811423975">18</xref>
</sup>
</p>
<p>The suggested bilirubin-induced angiogenesis may rely on the increased production of vascular endothelial growth factor observed here and is supported by the recent report of its increased production by human brain microvascular endothelial cells upon in vitro prolonged exposure to bilirubin.<sup>
<xref ref-type="bibr" rid="bibr18-0883073811423975">18</xref>
</sup> As accepted for hypoxia,<sup>
<xref ref-type="bibr" rid="bibr20-0883073811423975">20</xref>
</sup> it is conceivable that the upregulation of the vascular factor expression in the kernicterus case constitutes a defense mechanism to re-establish brain parenchyma homeostasis.</p>
<p>Vascular endothelial growth factor, also known as vascular permeability factor, is induced in response to signals such as cytokines.<sup>
<xref ref-type="bibr" rid="bibr35-0883073811423975">35</xref>
</sup> Interestingly, in our previous studies we showed that bilirubin induces the production of cytokines by glial cells,<sup>
<xref ref-type="bibr" rid="bibr36-0883073811423975">36</xref>
</sup> thus rendering conceivable that the increased staining for the vascular permeability factor that was observed follows an enhanced production of cytokines. Accordingly, we lately observed that high levels of bilirubin and long term-exposure also trigger the production of cytokines by human brain microvascular endothelial cells and that the secretion of interleukin 6 precedes that of vascular endothelial growth factor.<sup>
<xref ref-type="bibr" rid="bibr18-0883073811423975">18</xref>
</sup> On the other hand, the permeability effect of the vascular permeability factor has been linked to oxidative stress, namely by induction of endothelial nitric oxide synthase and nitric oxide production.<sup>
<xref ref-type="bibr" rid="bibr20-0883073811423975">20</xref>
</sup> Accordingly, bilirubin showed to induce endothelial nitric oxide expression and nitric oxide production in human brain microvascular endothelial cells,<sup>
<xref ref-type="bibr" rid="bibr18-0883073811423975">18</xref>
</sup> whereas autopsy analysis of several cases of bilirubin encephalopathy reinforced the concept that oxidative damage is implicated in brain lesions by bilirubin.<sup>
<xref ref-type="bibr" rid="bibr37-0883073811423975">37</xref>
</sup> Binding of vascular endothelial growth factor to endothelial cell surface receptors initiates distinct signaling cascades, namely phosphorylation of tight junctions and adherens junctions proteins. Such phosphorylation causes the junction complex to dissociate from its cytoskeleton anchor, leading to a weakened cell–cell adhesion and paracellular hyperpermeability.<sup>
<xref ref-type="bibr" rid="bibr20-0883073811423975">20</xref>
</sup> Therefore, in addition to the entrance of bilirubin into the brain by diffusion, it is conceivable that the permeability effect of vascular endothelial growth factor further facilitates bilirubin delivery to the brain. This would explain the preferential bilirubin deposition and cell damage.<sup>
<xref ref-type="bibr" rid="bibr38-0883073811423975">38</xref>,<xref ref-type="bibr" rid="bibr39-0883073811423975">39</xref>
</sup>
</p>
<p>Vascular endothelial growth factor has been implicated in the pathogenesis of brain edema,<sup>
<xref ref-type="bibr" rid="bibr40-0883073811423975">40</xref>
</sup> a finding observed in the present report. This factor has also been correlated with demyelination and with a loss of axons.<sup>
<xref ref-type="bibr" rid="bibr41-0883073811423975">41</xref>
</sup> Interestingly, the poor Luxol fast blue–periodic acid Schiff and Bodian-Luxol fast blue stainings exhibited in this kernicterus case reflect a loss of myelin fibers and of axons, whereas the poor immunoreactivity for neurofilaments reveals a loss of the neuronal cytoskeleton protein throughout the neuritic network. These observations are consistent with previous in vitro studies showing an impairment of neuritic network<sup>
<xref ref-type="bibr" rid="bibr9-0883073811423975">9</xref>
</sup> involving both axonal and dendritic outgrowth<sup>
<xref ref-type="bibr" rid="bibr16-0883073811423975">16</xref>
</sup> following exposure to bilirubin, as well as with neuronal degeneration observed at autopsy of several cases of bilirubin encephalopathy.<sup>
<xref ref-type="bibr" rid="bibr37-0883073811423975">37</xref>
</sup> Moreover, chronic neuronal loss and demyelination were observed in autopsy specimens of children past the newborn period<sup>
<xref ref-type="bibr" rid="bibr42-0883073811423975">42</xref>
</sup> and a wide spectrum of early white matter changes were noticed by MRI both in preterm and term infants with kernicterus.<sup>
<xref ref-type="bibr" rid="bibr22-0883073811423975">22</xref>
</sup> These authors claim that an MRI scan at least at 5 month post-term age is needed when kernicterus is suspected, once reduction of white matter volume and delay in hemispheric myelination were only revealed on late scans in infants with severe outcomes.</p>
<p>What still needs to be highlighted is the increased vascular endothelial growth factor expression together with the decreased immunoreactivity for neurofilaments observed in Purkinje neurons of the kernicterus cerebellum sections, which may underline the preferential injury of Purkinje neurons by bilirubin.<sup>
<xref ref-type="bibr" rid="bibr23-0883073811423975">23</xref>
</sup> Collectively, these perturbations of the cerebellum, including those of the white matter tracts, are compatible with the previously reported demyelination in areas related to the abnormal tone and coordination characteristics of kernicterus.<sup>
<xref ref-type="bibr" rid="bibr3-0883073811423975">3</xref>
</sup>
</p>
<p>The upregulation of vascular endothelial growth factor was paralleled by an increased expression of its receptor 2, suggesting an autocrine/paracrine effect of bilirubin on brain neurons that can perpetuate the perturbation of neuronal homeostasis. As far as we know, these features were never reported in neurons of the nucleus dentatus, hence deserving further investigation. Regarding vascular endothelial growth factor accumulation in neurons, it remains to be clarified whether these cells are the producers or the main targets of the vascular permeability factor.</p>
<p>We hypothesized that the degenerating neurons would be subjected to phagocytosis by the brain resident immunocompetent cells, microglia, based on their phagocytic phenotype when exposed to bilirubin.<sup>
<xref ref-type="bibr" rid="bibr17-0883073811423975">17</xref>
</sup> However, immunohistochemical analysis of major histocompatibility complex II–expressing cells (CR3/43) and of cluster of differentiation 68 (PG-M1) antigen, usual markers of activated microglia and bloodborne macrophages, respectively, revealed no changes in the morphology or density of microglia. These apparently contradictory findings may be explained if distant microglia are not recruited to the site of neuronal injury by bilirubin. In fact, while bilirubin associated with intracerebral hemorrhage showed to increase neutrophil infiltration, a reduced number of microglia were seen at the site of lesion.<sup>43</sup>
</p>
<p>Previous studies have pointed out that bilirubin is a substrate for multidrug resistance–associated protein 1 and that this efflux pump protein has a neuroprotective role in preventing bilirubin-induced brain damage.<sup>
<xref ref-type="bibr" rid="bibr8-0883073811423975">8</xref>,<xref ref-type="bibr" rid="bibr44-0883073811423975">44</xref>
</sup> However, it was recently demonstrated that prolonged exposure to high levels of bilirubin causes a downregulation of multidrug resistance–associated protein 1 in choroid plexuses isolated from hyperbilirubinemic jj Gunn rat pups as compared with their nonjaundiced Jj littermate controls.<sup>
<xref ref-type="bibr" rid="bibr45-0883073811423975">45</xref>
</sup> Nevertheless, an upregulation of the protein expression was observed in cerebellar neurons of the present case of kernicterus. This suggests that multidrug resistance–associated protein 1 offered a marginal defense against bilirubin deposition in the brain or that the prolonged and/or markedly elevated levels of bilirubin exceeded its cytoprotective capacity, yielding consequent and fatal neurotoxicity. In fact, Purkinje cell injury occurs by prolonged and/or markedly elevated levels of bilirubin.<sup>
<xref ref-type="bibr" rid="bibr46-0883073811423975">46</xref>
</sup> We may also speculate that the increased permeability of the blood-brain barrier that may occur after prolonged exposure to high levels of bilirubin, as previously discussed, could have favored a paracellular route for bilirubin access into the brain, circumventing these transporters.</p>
<p>In conclusion, the autopsy analysis of a preterm infant dead with the diagnosis of kernicterus suggests that the disease is accompanied by a loss of myelin fibers and an impairment of neuritic network. Although an upregulation of multidrug resistance–associated protein 1 also occurs, it appears to constitute an insufficient mechanism to prevent brain bilirubin deposition. Most interesting is the up-regulation of the vascular permeability factor and its receptor 2 in cerebellar neurons, together with the angiogenic sprouting and increased brain vascularization observed in the kernicterus patient, pointing to these agents as new players in the neuropathology of kernicterus. Although relying on a single case study, the observations reported here are supported by in vitro data and open new avenues for future research aiming to better understand whether neovascularization is a determinant or a secondary event in bilirubin encephalopathy.</p>
</sec>
</body>
<back>
<ack>
<title>Acknowledgments</title>
<p>Part of this work was performed at the Faculty of Pharmacy, University of Lisbon, and at the Laboratory of Neuropathology, Hospital de Santa Maria, in Lisbon, Portugal, and part at the Department of (Neuro)Pathology, Academic Medical Center, University of Amsterdam, The Netherlands. We thank Cibelle Mariano and Inês Sá Pereira for assistance in stainings.</p>
</ack>
<fn-group>
<fn fn-type="other" id="fn1-0883073811423975">
<p>MAB established the international collaboration, performed part of the experimental work, assembled the manuscript for publication, and provided part of the financial support for this work; EZ and PP performed the histologic and immunohistochemical analysis; CB offered the conditions for the realization of the work performed in the Hospital de Santa Maria, in Lisbon, and provided expert clinical insights; EA was responsible for the case selection, supervision of the work performed in the Netherlands, and also provided helpful contribution for the interpretation of the findings. DB provided helpful discussion of the work, actively participated in manuscript preparation, and also provided part of the financial support.</p>
</fn>
<fn fn-type="conflict" id="fn2-0883073811423975">
<p>The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article. </p>
</fn>
<fn fn-type="financial-disclosure" id="fn3-0883073811423975">
<p>The authors disclosed receipt of the following financial support for the research and/or authorship of this article. This work was supported by the Fundação para a Ciência e a Tecnologia, Portugal [grants numbers PTDC/SAU-FCF/68819/2006 and PTDC/SAU-NEU/64385/2006]. </p>
</fn>
<fn fn-type="other" id="fn4-0883073811423975">
<p>The samples studied were obtained from the files of the department of neuropathology of the Academic Medical Center, University of Amsterdam, and the study was approved in the Institutions where it was undertaken. Tissue was obtained and used in a manner compliant with the Declaration of Helsinki, as revised in 1983, after appropriate maternal consent for brain autopsy.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-0883073811423975">
<label>1</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Brito</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Silva</surname>
<given-names>RFM</given-names>
</name>
<name>
<surname>Brites</surname>
<given-names>D</given-names>
</name>
</person-group>. <article-title>Cell response to hyperbilirubinemia: a journey along key molecular events</article-title>. In <person-group person-group-type="editor">
<name>
<surname>Chen</surname>
<given-names>FJ</given-names>
</name>
</person-group>, ed. <source>New Trends in Brain Research</source>. <publisher-loc>New York</publisher-loc>: <publisher-name>Nova Science</publisher-name>; <year>2006</year>:<fpage>1</fpage>–<lpage>38</lpage>.</citation>
</ref>
<ref id="bibr2-0883073811423975">
<label>2</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Smitherman</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Stark</surname>
<given-names>AR</given-names>
</name>
<name>
<surname>Bhutani</surname>
<given-names>VK</given-names>
</name>
</person-group>. <article-title>Early recognition of neonatal hyperbilirubinemia and its emergent management</article-title>. <source>Semin Fetal Neonatal Med</source>. <year>2006</year>;<volume>11</volume>(<issue>3</issue>):<fpage>214</fpage>–<lpage>224</lpage>.</citation>
</ref>
<ref id="bibr3-0883073811423975">
<label>3</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shapiro</surname>
<given-names>SM</given-names>
</name>
</person-group>. <article-title>Chronic bilirubin encephalopathy: diagnosis and outcome</article-title>. <source>Semin Fetal Neonatal Med</source>. <year>2010</year>;<volume>15</volume>(<issue>3</issue>):<fpage>157</fpage>–<lpage>163</lpage>.</citation>
</ref>
<ref id="bibr4-0883073811423975">
<label>4</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bhutani</surname>
<given-names>VK</given-names>
</name>
<name>
<surname>Johnson</surname>
<given-names>L</given-names>
</name>
</person-group>. <article-title>Prevention of severe neonatal hyperbilirubinemia in healthy infants of 35 or more weeks of gestation: implementation of a systems-based approach</article-title>. <source>J Pediatr (Rio J)</source>. <year>2007</year>;<volume>83</volume>(<issue>4</issue>):<fpage>289</fpage>–<lpage>293</lpage>.</citation>
</ref>
<ref id="bibr5-0883073811423975">
<label>5</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ebbesen</surname>
<given-names>F</given-names>
</name>
</person-group>. <article-title>Recurrence of kernicterus in term and near-term infants in Denmark</article-title>. <source>Acta Paediatr</source>. <year>2000</year>;<volume>89</volume>(<issue>10</issue>):<fpage>1213</fpage>–<lpage>1217</lpage>.</citation>
</ref>
<ref id="bibr6-0883073811423975">
<label>6</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hansen</surname>
<given-names>TWR</given-names>
</name>
</person-group>. <article-title>Kernicterus in term and near-term infants—the specter walks again</article-title>. <source>Acta Paediatr</source>. <year>2000</year>;<volume>89</volume>(<issue>10</issue>):<fpage>1155</fpage>–<lpage>1157</lpage>.</citation>
</ref>
<ref id="bibr7-0883073811423975">
<label>7</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Palmer</surname>
<given-names>RH</given-names>
</name>
<name>
<surname>Keren</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Maisels</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Yeargin-Allsopp</surname>
<given-names>M</given-names>
</name>
</person-group>. <article-title>National Institute of Child Health and Human Development (NICHD) conference on kernicterus: a population perspective on prevention of kernicterus</article-title>. <source>J Perinatol</source>. <year>2004</year>;<volume>24</volume>(<issue>11</issue>):<fpage>723</fpage>–<lpage>725</lpage>.</citation>
</ref>
<ref id="bibr8-0883073811423975">
<label>8</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Falcão</surname>
<given-names>AS</given-names>
</name>
<name>
<surname>Bellarosa</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Fernandes</surname>
<given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>Role of multidrug resistance-associated protein 1 expression in the in vitro susceptibility of rat nerve cell to unconjugated bilirubin</article-title>. <source>Neuroscience</source>. <year>2007</year>;<volume>144</volume>(<issue>3</issue>):<fpage>878</fpage>–<lpage>888</lpage>.</citation>
</ref>
<ref id="bibr9-0883073811423975">
<label>9</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Falcão</surname>
<given-names>AS</given-names>
</name>
<name>
<surname>Silva</surname>
<given-names>RFM</given-names>
</name>
<name>
<surname>Pancadas</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Fernandes</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Brito</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Brites</surname>
<given-names>D</given-names>
</name>
</person-group>. <article-title>Apoptosis and impairment of neurite network by short exposure of immature rat cortical neurons to unconjugated bilirubin increase with cell differentiation and are additionally enhanced by an inflammatory stimulus</article-title>. <source>J Neurosci Res</source>. <year>2007</year>;<volume>85</volume>(<issue>6</issue>):<fpage>1229</fpage>–<lpage>1239</lpage>.</citation>
</ref>
<ref id="bibr10-0883073811423975">
<label>10</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brito</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Brites</surname>
<given-names>D</given-names>
</name>
</person-group>. <article-title>Effect of acidosis on bilirubin-induced toxicity to human erythrocytes</article-title>. <source>Mol Cell Biochem</source>. <year>2003</year>;<volume>247</volume>(<issue>1-2</issue>):<fpage>155</fpage>–<lpage>162</lpage>.</citation>
</ref>
<ref id="bibr11-0883073811423975">
<label>11</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fernandes</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Silva</surname>
<given-names>RFM</given-names>
</name>
<name>
<surname>Falcão</surname>
<given-names>AS</given-names>
</name>
<name>
<surname>Brito</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Brites</surname>
<given-names>D</given-names>
</name>
</person-group>. <article-title>Cytokine production, glutamate release and cell death in rat cultured astrocytes treated with unconjugated bilirubin and LPS</article-title>. <source>J Neuroimmunol</source>. <year>2004</year>;<volume>153</volume>(<issue>1-2</issue>):<fpage>64</fpage>–<lpage>75</lpage>.</citation>
</ref>
<ref id="bibr12-0883073811423975">
<label>12</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vaz</surname>
<given-names>AR</given-names>
</name>
<name>
<surname>Silva</surname>
<given-names>SL</given-names>
</name>
<name>
<surname>Barateiro</surname>
<given-names>A</given-names>
</name>
</person-group>
<etal/>. <article-title>Pro-inflammatory cytokines intensify the activation of NO/NOS, JNK1/2 and caspase cascades in immature neurons exposed to elevated levels of unconjugated bilirubin</article-title>. <source>Exp Neurol</source>. <year>2011</year>;<volume>229</volume>(<issue>2</issue>):<fpage>381</fpage>–<lpage>390</lpage>.</citation>
</ref>
<ref id="bibr13-0883073811423975">
<label>13</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dennery</surname>
<given-names>PA</given-names>
</name>
<name>
<surname>Seidman</surname>
<given-names>DS</given-names>
</name>
<name>
<surname>Stevenson</surname>
<given-names>DK</given-names>
</name>
</person-group>. <article-title>Neonatal hyperbilirubinemia</article-title>. <source>N Engl J Med</source>. <year>2001</year>;<volume>344</volume>(<issue>8</issue>):<fpage>581</fpage>–<lpage>590</lpage>.</citation>
</ref>
<ref id="bibr14-0883073811423975">
<label>14</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Watchko</surname>
<given-names>JF</given-names>
</name>
<name>
<surname>Maisels</surname>
<given-names>MJ</given-names>
</name>
</person-group>. <article-title>Jaundice in low birthweight infants: pathobiology and outcome</article-title>. <source>Arch Dis Child Fetal Neonatal Ed</source>. <year>2003</year>;<volume>88</volume>(<issue>6</issue>):<fpage>F455</fpage>–<lpage>F458</lpage>.</citation>
</ref>
<ref id="bibr15-0883073811423975">
<label>15</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brito</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Rosa</surname>
<given-names>AI</given-names>
</name>
<name>
<surname>Falc</surname>
</name>
<name>
<surname>ão</surname>
<given-names>AS, et al.</given-names>
</name>
</person-group> <article-title>Unconjugated bilirubin differentially affects the redox status of neuronal and astroglial cells</article-title>. <source>Neurobiol Dis</source>. <year>2008</year>;<volume>29</volume>(<issue>1</issue>):<fpage>30</fpage>–<lpage>40</lpage>.</citation>
</ref>
<ref id="bibr16-0883073811423975">
<label>16</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fernandes</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Falcão</surname>
<given-names>AS</given-names>
</name>
<name>
<surname>Abranches</surname>
<given-names>E</given-names>
</name>
<etal/></person-group>. <article-title>Bilirubin as a determinant for altered neurogenesis, neuritogenesis, and synaptogenesis</article-title>. <source>Dev Neurobiol</source>. <year>2009</year>;<volume>69</volume>(<issue>9</issue>):<fpage>568</fpage>–<lpage>582</lpage>.</citation>
</ref>
<ref id="bibr17-0883073811423975">
<label>17</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Silva</surname>
<given-names>SL</given-names>
</name>
<name>
<surname>Vaz</surname>
<given-names>AR</given-names>
</name>
<name>
<surname>Barateiro</surname>
<given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>Features of bilirubin-induced reactive microglia: from phagocytosis to inflammation</article-title>. <source>Neurobiol Dis</source>. <year>2010</year>;<volume>40</volume>(<issue>3</issue>):<fpage>663</fpage>–<lpage>675</lpage>.</citation>
</ref>
<ref id="bibr18-0883073811423975">
<label>18</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Palmela</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Cardoso</surname>
<given-names>FL</given-names>
</name>
<name>
<surname>Bernas</surname>
<given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>Elevated levels of bilirubin and long-term exposure impair human brain microvascular endothelial cell integrity</article-title>. <source>Curr Neurovasc Res</source>. <year>2011</year>;<volume>8</volume>(<issue>2</issue>):<fpage>153</fpage>–<lpage>169</lpage>.</citation>
</ref>
<ref id="bibr19-0883073811423975">
<label>19</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dulak</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Łoboda</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Zagórska</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Józkowicz</surname>
<given-names>A</given-names>
</name>
</person-group>. <article-title>Complex role of heme oxygenase-1 in angiogenesis</article-title>. <source>Antioxid Redox Signal</source>. <year>2004</year>;<volume>6</volume>(<issue>5</issue>):<fpage>858</fpage>–<lpage>866</lpage>.</citation>
</ref>
<ref id="bibr20-0883073811423975">
<label>20</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cardoso</surname>
<given-names>FL</given-names>
</name>
<name>
<surname>Brites</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Brito</surname>
<given-names>MA</given-names>
</name>
</person-group>. <article-title>Looking at the blood-brain barrier: molecular anatomy and possible investigation approaches</article-title>. <source>Brain Res Rev</source>. <year>2010</year>;<volume>64</volume>(<issue>2</issue>):<fpage>328</fpage>–<lpage>363</lpage>.</citation>
</ref>
<ref id="bibr21-0883073811423975">
<label>21</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Perlman</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Rogers</surname>
<given-names>BB</given-names>
</name>
<name>
<surname>Burns</surname>
<given-names>D</given-names>
</name>
</person-group>. <article-title>Kernicteric findings at autopsy in two sick near term infants</article-title>. <source>Pediatrics</source>. <year>1997</year>;<volume>99</volume>(<issue>4</issue>):<fpage>612</fpage>–<lpage>615</lpage>.</citation>
</ref>
<ref id="bibr22-0883073811423975">
<label>22</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gkoltsiou</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Tzoufi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Counsell</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Rutherford</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Cowan</surname>
<given-names>F</given-names>
</name>
</person-group>. <article-title>Serial brain MRI and ultrasound findings: relation to gestational age, bilirubin level, neonatal neurologic status and neurodevelopmental outcome in infants at risk of kernicterus</article-title>. <source>Early Hum Dev</source>. <year>2008</year>;<volume>84</volume>(<issue>12</issue>):<fpage>829</fpage>–<lpage>838</lpage>.</citation>
</ref>
<ref id="bibr23-0883073811423975">
<label>23</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schutta</surname>
<given-names>HS</given-names>
</name>
<name>
<surname>Johnson</surname>
<given-names>L</given-names>
</name>
</person-group>. <article-title>Bilirubin encephalopathy in the Gunn rat: a fine structure study of the cerebellar cortex</article-title>. <source>J Neuropathol Exp Neurol</source>. <year>1967</year>;<volume>26</volume>(<issue>3</issue>):<fpage>377</fpage>–<lpage>396</lpage>.</citation>
</ref>
<ref id="bibr24-0883073811423975">
<label>24</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lin</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Bales</surname>
<given-names>KR</given-names>
</name>
<etal/>
</person-group>. <article-title>Minocycline blocks bilirubin neurotoxicity and prevents hyperbilirubinemia-induced cerebellar hypoplasia in the Gunn rat</article-title>. <source>Eur J Neurosci</source>. <year>2005</year>;<volume>22</volume>(<issue>1</issue>):<fpage>21</fpage>–<lpage>27</lpage>.</citation>
</ref>
<ref id="bibr25-0883073811423975">
<label>25</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aronica</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Gorter</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Jansen</surname>
<given-names>GH</given-names>
</name>
<etal/>
</person-group>. <article-title>Expression and cellular distribution of multidrug transporter proteins in two major causes of medically intractable epilepsy: focal cortical dysplasia and glioneuronal tumors</article-title>. <source>Neuroscience</source>. <year>2003</year>;<volume>118</volume>(<issue>2</issue>):<fpage>417</fpage>–<lpage>429</lpage>.</citation>
</ref>
<ref id="bibr26-0883073811423975">
<label>26</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Boer</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Troost</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Jansen</surname>
<given-names>F</given-names>
</name>
<etal/>
</person-group>. <article-title>Clinicopathological and immunohistochemical findings in an autopsy case of tuberous sclerosis complex</article-title>. <source>Neuropathology</source>. <year>2008</year>;<volume>28</volume>(<issue>6</issue>):<fpage>577</fpage>–<lpage>590</lpage>.</citation>
</ref>
<ref id="bibr27-0883073811423975">
<label>27</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bellarosa</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Bortolussi</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Tiribelli</surname>
<given-names>C</given-names>
</name>
<etal/>
</person-group>. <article-title>The role of ABC transporters in protecting cells from bilirubin toxicity</article-title>. <source>Curr Pharm Des</source>. <year>2009</year>;<volume>15</volume>(<issue>25</issue>):<fpage>2884</fpage>–<lpage>2892</lpage>.</citation>
</ref>
<ref id="bibr28-0883073811423975">
<label>28</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wennberg</surname>
<given-names>RP.</given-names>
</name>
</person-group> <article-title>The blood-brain barrier and bilirubin encephalopathy</article-title>.
<source>Cell Mol Neurobiol</source>. <year>2000</year>;<volume>20</volume>(<issue>1</issue>):<fpage>97</fpage>–<lpage>109</lpage>.</citation>
</ref>
<ref id="bibr29-0883073811423975">
<label>29</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Burgess</surname>
<given-names>GH</given-names>
</name>
<name>
<surname>Oh</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Bratlid</surname>
<given-names>D</given-names>
</name>
</person-group>
<etal/>. <article-title>The effects of brain blood flow on brain bilirubin deposition in newborn piglets</article-title>. <source>Pediatr Res</source>. <year>1985</year>;<volume>19</volume>(<issue>7</issue>):<fpage>691</fpage>–<lpage>696</lpage>.</citation>
</ref>
<ref id="bibr30-0883073811423975">
<label>30</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Stuhlmann</surname>
<given-names>H</given-names>
</name>
</person-group>. <article-title>In vitro imaging of angiogenesis using embryonic stem cell-derived endothelial cells</article-title>. <source>Stem Cells Dev</source>. <year>2011</year> <comment>[published ahead of print April 27, doi:10.1089/scd.2010.0587].</comment>
</citation>
</ref>
<ref id="bibr31-0883073811423975">
<label>31</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Raimondi</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Crivaro</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Capasso</surname>
<given-names>L</given-names>
</name>
<etal/>
</person-group>. <article-title>Unconjugated bilirubin modulates the intestinal epithelial barrier function in a human-derived in vitro model</article-title>. <source>Pediatr Res</source>. <year>2006</year>;<volume>60</volume>(<issue>1</issue>):<fpage>30</fpage>–<lpage>33</lpage>.</citation>
</ref>
<ref id="bibr32-0883073811423975">
<label>32</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>McCall</surname>
<given-names>IC</given-names>
</name>
<name>
<surname>Betanzos</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Weber</surname>
<given-names>DA</given-names>
</name>
<name>
<surname>Nava</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Miller</surname>
<given-names>GW</given-names>
</name>
<name>
<surname>Parkos</surname>
<given-names>CA</given-names>
</name>
</person-group>. <article-title>Effects of phenol on barrier function of a human intestinal epithelial cell line correlate with altered tight junction protein localization</article-title>. <source>Toxicol Appl Pharmacol</source>. <year>2009</year>;<volume>241</volume>(<issue>1</issue>):<fpage>61</fpage>–<lpage>70</lpage>.</citation>
</ref>
<ref id="bibr33-0883073811423975">
<label>33</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brito</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Brondino</surname>
<given-names>CD</given-names>
</name>
<name>
<surname>Moura</surname>
<given-names>JJG</given-names>
</name>
<name>
<surname>Brites</surname>
<given-names>D</given-names>
</name>
</person-group>. <article-title>Effects of bilirubin molecular species on membrane dynamic properties of human erythrocyte membranes: a spin label electron paramagnetic resonance spectroscopy study</article-title>. <source>Arch Biochem Biophys</source>. <year>2001</year>;<volume>387</volume>(<issue>1</issue>):<fpage>57</fpage>–<lpage>65</lpage>.</citation>
</ref>
<ref id="bibr34-0883073811423975">
<label>34</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rodrigues</surname>
<given-names>CMP</given-names>
</name>
<name>
<surname>Solá</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Brito</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Brites</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Moura</surname>
<given-names>JJG</given-names>
</name>
</person-group>. <article-title>Bilirubin directly disrupts membrane lipid polarity and fluidity, protein order, and redox status in rat mitochondria</article-title>. <source>J Hepatol</source>. <year>2002</year>;<volume>36</volume>(<issue>3</issue>):<fpage>335</fpage>–<lpage>341</lpage>.</citation>
</ref>
<ref id="bibr35-0883073811423975">
<label>35</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pagès</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Pouysségur</surname>
<given-names>J</given-names>
</name>
</person-group>. <article-title>Transcriptional regulation of the vascular endothelial growth factor gene—a concert of activating factors</article-title>. <source>Cardiovasc Res</source>. <year>2005</year>;<volume>65</volume>(<issue>3</issue>):<fpage>564</fpage>–<lpage>573</lpage>.</citation>
</ref>
<ref id="bibr36-0883073811423975">
<label>36</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brites</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Fernandes</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Falcão</surname>
<given-names>AS</given-names>
</name>
<name>
<surname>Gordo</surname>
<given-names>AC</given-names>
</name>
<name>
<surname>Silva</surname>
<given-names>RFM</given-names>
</name>
<name>
<surname>Brito</surname>
<given-names>MA</given-names>
</name>
</person-group>. <article-title>Biological risks for neurological abnormalities associated with hyperbilirubinemia</article-title>. <source>J Perinatol</source>. <year>2009</year>;<volume>29</volume>(<issue>suppl 1</issue>):<fpage>S8</fpage>–<lpage>S13</lpage>.</citation>
</ref>
<ref id="bibr37-0883073811423975">
<label>37</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hachiya</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Hayashi</surname>
<given-names>M</given-names>
</name>
</person-group>. <article-title>Bilirubin encephalopathy: a study of neuronal subpopulations and neurodegenerative mechanisms in 12 autopsy cases</article-title>. <source>Brain Dev</source>. <year>2008</year>;<volume>30</volume>(<issue>4</issue>):<fpage>269</fpage>–<lpage>278</lpage>.</citation>
</ref>
<ref id="bibr38-0883073811423975">
<label>38</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Watchko</surname>
<given-names>JF</given-names>
</name>
</person-group>. <article-title>Kernicterus and the molecular mechanisms of bilirubin-induced CNS injury in newborns</article-title>. <source>Neuromolecular Med</source>. <year>2006</year>;<volume>8</volume>(<issue>4</issue>):<fpage>513</fpage>–<lpage>529</lpage>.</citation>
</ref>
<ref id="bibr39-0883073811423975">
<label>39</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Daood</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Tsai</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Ahdab-Barmada</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Watchko</surname>
<given-names>JF. </given-names>
</name>
</person-group>
<article-title>ABC transporter (P-gp/ABCB1, MRP1/ABCC1, BCRP/ABCG2) expression in the developing human CNS</article-title>. <source>Neuropediatrics</source>. <year>2008</year>;<volume>39</volume>(<issue>4</issue>):<fpage>211</fpage>–<lpage>218</lpage>.</citation>
</ref>
<ref id="bibr40-0883073811423975">
<label>40</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nag</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Manias</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Stewart</surname>
<given-names>DJ</given-names>
</name>
</person-group>. <article-title>Pathology and new players in the pathogenesis of brain edema</article-title>. <source>Acta Neuropathol</source>. <year>2009</year>;<volume>118</volume>(<issue>2</issue>):<fpage>197</fpage>–<lpage>217</lpage>.</citation>
</ref>
<ref id="bibr41-0883073811423975">
<label>41</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Roscoe</surname>
<given-names>WA</given-names>
</name>
<name>
<surname>Welsh</surname>
<given-names>ME</given-names>
</name>
<name>
<surname>Carter</surname>
<given-names>DE</given-names>
</name>
<name>
<surname>Karlik</surname>
<given-names>SJ</given-names>
</name>
</person-group>. <article-title>VEGF and angiogenesis in acute and chronic MOG((35-55)) peptide induced EAE</article-title>. <source>J Neuroimmunol</source>. <year>2009</year>;<volume>209</volume>(<issue>1-2</issue>):<fpage>6</fpage>–<lpage>15</lpage>.</citation>
</ref>
<ref id="bibr42-0883073811423975">
<label>42</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Martich-Kriss</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Kollias</surname>
<given-names>SS</given-names>
</name>
<name>
<surname>Ball</surname>
<given-names>WS</given-names>
<suffix> Jr</suffix>
</name>
</person-group>. <article-title>MR findings in kernicterus</article-title>. <source>AJNR Am J Neuroradiol</source>. <year>1995</year>;<volume>16</volume>(<issue>4suppl</issue>):<fpage>819</fpage>–<lpage>821</lpage>.</citation>
</ref>
<ref id="bibr43-0883073811423975">
<label>43</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Loftspring</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Johnson</surname>
<given-names>HL</given-names>
</name>
<name>
<surname>Feng</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Johnson</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Clark</surname>
<given-names>JF</given-names>
</name></person-group>. <article-title>Unconjugated bilirubin contributes to early inflammation and edema after intracerebral hemorrhage</article-title>. <source>J Cereb Blood Flow Metab</source>. <year>2011</year>;<volume>31</volume>(<issue>4</issue>):<fpage>1133</fpage>–<lpage>1142</lpage>.</citation>
</ref>
<ref id="bibr44-0883073811423975">
<label>44</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Corich</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Aranda</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Carrassa</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Bellarosa</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Ostrow</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Tiribelli</surname>
<given-names>C</given-names>
</name>
</person-group>. <article-title>The cytotoxic effect of unconjugated bilirubin in human neuroblastoma SH-SY5Y cells is modulated by the expression level of MRP1 but not MDR1</article-title>. <source>Biochem J</source>. <year>2009</year>;<volume>417</volume>(<issue>1</issue>):<fpage>305</fpage>–<lpage>312</lpage>.</citation>
</ref>
<ref id="bibr45-0883073811423975">
<label>45</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gazzin</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Berengeno</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>Strazielle</surname>
<given-names>N</given-names>
</name>
</person-group>
<etal/> <article-title>Modulation of Mrp1 (ABCc1) and Pgp (ABCb1) by bilirubin at the blood-CSF and blood-brain barriers in the Gunn rat</article-title>. <source>PLoS One</source> <year>2011</year>;<volume>6</volume>(<issue>1</issue>):<fpage>e16165</fpage>.</citation>
</ref>
<ref id="bibr46-0883073811423975">
<label>46</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Conlee</surname>
<given-names>JW</given-names>
</name>
<name>
<surname>Shapiro</surname>
<given-names>SM</given-names>
</name>
</person-group>. <article-title>Development of cerebellar hypoplasia in jaundiced Gunn rats: a quantitative light microscopic analysis</article-title>. <source>Acta Neuropathol</source>. <year>1997</year>;<volume>93</volume>(<issue>5</issue>):<fpage>450</fpage>–<lpage>460</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>